The Swiss Paul Scherrer Institute (PSI) in Villigen and Siemens Medical Solutions (Med) in Erlangen, Germany, have recently signed a cooperation contract. Both partners agreed to a closer collaboration in proton therapy planning – an important component of a particle therapy solution.
Within the scope of the agreement, Siemens has access to the know-how of the therapy planning system at the Paul Scherrer Institute. Both partners are joining forces to further develop proton therapy planning. Siemens will be provided with the opportunity of testing its own methods at PSI and will complement this offer by supporting research at the institute.
PSI is the only institute world-wide which uses so-called Spot Scanning for proton therapy. Spot Scanning is a method where the target volume is scanned via raster points to enable precise irradiation. PSI has been gathering clinical experience in treating patients with this method since 1996 and now more than 200 patients have been treated at the proton gantry. Additionally PSI has treated more than 4200 patients with eye melanomas using proton therapy since 1984.
Juanita Schlaepfer-Miller | alfa
PET imaging tracks Zika virus infection, disease progression in mouse model
20.09.2017 | US Army Medical Research Institute of Infectious Diseases
'Exciting' discovery on path to develop new type of vaccine to treat global viruses
18.09.2017 | University of Southampton
19.09.2017 | Event News
12.09.2017 | Event News
06.09.2017 | Event News
20.09.2017 | Life Sciences
20.09.2017 | Power and Electrical Engineering
20.09.2017 | Physics and Astronomy